NYNY - ETF AI Analysis
Top Page
Corgi NYC Based ETF (NYNY)
Rating:68Neutral
Price Target:―
Positive Factors
Solid Recent Performance
The ETF has delivered steady gains so far this year and over the past month, showing positive recent momentum.
Several Strong Top Holdings
Key positions like Goldman Sachs, Morgan Stanley, Citigroup, Verizon, Pfizer, Bristol-Myers Squibb, and Datadog have shown strong or improving performance, helping support the fund’s returns.
Moderate Expense Ratio
The fund’s expense ratio is relatively low for an actively chosen sector-focused ETF, which helps investors keep more of their returns over time.
Negative Factors
Heavy Financial Sector Concentration
With the majority of assets in financial stocks, the ETF is highly sensitive to problems in the banking and financial services industry.
Limited Geographic Diversification
Almost all holdings are in U.S. companies, so the fund offers little protection if the U.S. market faces a downturn.
Mixed Performance Among Top Holdings
Some large positions such as JPMorgan Chase, American Express, and BlackRock have shown weaker or negative performance, which could drag on overall returns if the trend continues.
NYNY vs. SPDR S&P 500 ETF (SPY)
AUM689.01K
RegionNorth America
Expense Ratio0.20%
Beta0.34
IssuerCorgi
Inception DateMay 06, 2026
Dividend YieldN/A
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume991
30 Day Avg. Volume710
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
31.24Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering51
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
NYNY Summary
Corgi NYC Based ETF (ticker: NYNY) is an actively managed fund that focuses on companies tied to the New York City area rather than tracking a standard index. It holds a mix of large and smaller firms across many industries, with a big tilt toward financials. Well-known holdings include JPMorgan Chase and Goldman Sachs, along with companies like Verizon and Pfizer. Someone might invest in this ETF to get diversified exposure to the businesses that drive New York’s economy in a single investment. A key risk is that it’s heavily concentrated in one region and can rise or fall with New York City’s local economy.
How much will it cost me?This ETF has an expense ratio of 0.20%, which means you’ll pay about $2 per year for every $1,000 you invest. That cost is a bit higher than many broad, passively managed index ETFs because this fund is actively managed and focuses on a specialized slice of the market (companies tied to New York City).
What would affect this ETF?This ETF is heavily tied to New York City’s financial and real estate scene, so it could benefit if banks like JPMorgan, Goldman Sachs, and Morgan Stanley enjoy stronger profits, if NYC’s economy grows, and if demand for urban services, healthcare, and technology stays healthy. On the other hand, it could be hurt by rising interest rates that pressure banks and real estate, local economic slowdowns or stricter city and state regulations, and company-specific setbacks at major holdings like Verizon, Pfizer, or key financial firms.
NYNY Top 10 Holdings
NYNY is powered by Wall Street heavyweights, with JPMorgan, Morgan Stanley, Goldman Sachs, and Citigroup forming the core engine of the fund and generally rising, thanks to solid earnings and upbeat sentiment around financials. Verizon adds a steady, cash-generating telecom anchor that’s also been climbing, while Pfizer and Bristol-Myers Squibb provide a healthier dose of momentum from the pharma side. American Express is more mixed and has recently been lagging, slightly dragging on results. Overall, this is a New York–centric, U.S.-focused ETF with a clear tilt toward big financial names.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Pfizer | 4.76% | $33.15K | $158.39B | 8.46% | 74 Outperform | |
| Verizon | 4.67% | $32.53K | $204.37B | 11.27% | 81 Outperform | |
| American Express | 4.40% | $30.59K | $223.63B | 5.28% | 80 Outperform | |
| Morgan Stanley | 4.37% | $30.42K | $325.81B | 44.71% | 76 Outperform | |
| JPMorgan Chase | 4.36% | $30.37K | $934.49B | 18.68% | 72 Outperform | |
| BlackRock | 4.33% | $30.13K | $185.19B | 0.73% | 77 Outperform | |
| Citigroup | 4.32% | $30.03K | $217.51B | 38.20% | 68 Neutral | |
| Goldman Sachs Group | 4.26% | $29.63K | $291.74B | 40.08% | 73 Outperform | |
| S&P Global | 3.56% | $24.75K | $127.40B | -22.52% | 73 Outperform | |
| ― | 3.48% | $24.25K | ― | ― | ― |
NYNY Technical Analysis
Positive
―
Price Trends
26.99
Positive
Market Momentum
0.26
Positive
59.94
Neutral
38.58
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For NYNY, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 27.60, equal to the 50-day MA of 26.99, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of 0.26 indicates Positive momentum. The RSI at 59.94 is Neutral, neither overbought nor oversold. The STOCH value of 38.58 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for NYNY.
NYNY Peer Comparison
Comparison Results
Performance Comparison
NYNY
Corgi NYC Based ETF
27.90
2.56
10.10%
STNC
Stance Equity ESG Large Cap Core ETF
―
―
―
PFOE
Pathfinder Focused Opportunities ETF
―
―
―
SOVF
Sovereign's Capital Flourish Fund
―
―
―
YALL
God Bless America ETF
―
―
―
VAMO
Cambria Value & Momentum ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents